Results 231 to 240 of about 12,877,669 (294)

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria

Medicinal Research Reviews, Volume 46, Issue 6, Page 1477-1498, November 2026.
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood, Jacinta R. Macdonald, Christian Anzenhofer, Tina S. Skinner‐Adams, Robert C. Reid, Thomas Kurz, David P. Fairlie, Katherine T. Andrews   +7 more
wiley   +1 more source

Disseminated Phaeohyphomycosis Due to <i>Alternaria alternata</i> in a Liver Transplant Recipient: Successful Treatment With Isavuconazole, a Case Report and Literature Review. [PDF]

Case Rep Transplant
Tapia-Villacis S, Prieto J, López M, Medina J.   +3 more
europepmc   +1 more source

Design, Synthesis and Biophysical Characterisation of CPP‐PNA Conjugates for Targeting Oncogenic microRNA‐221

Journal of Peptide Science, Volume 32, Issue 11, November 2026.
Cell‐penetrating peptide‐peptide nucleic acid (CPP‐PNA) conjugates that target the oncogenic microRNA‐221‐5p were synthesised using Cu(I)‐catalysed azide‐alkyne cycloaddition (CuAAC) and disulfide‐mediated conjugation strategies. These constructs form highly stable, sequence‐selective PNA/RNA heteroduplexes and demonstrate preliminary antiproliferative
Martina Rotondo, Françoise Illien, Fabienne Burlina, Barbara Biondi   +3 more
wiley   +1 more source

Primary Therapy for Invasive Aspergillosis With Triazoles or L-AmB: A Multicenter Retrospective Study. [PDF]

Open Forum Infect Dis
Rinaldi M, Lewis RE, Susini MC, Nuti B, Casarini M, Riccucci D, Grassi I, Toschi A, Bartoletti M, Bussini L, Bavaro DF, Cento V, Diella L, Belati A, De Angelis A, Barbanotti D, Pensalfine G, Ambretti S, Roncarati G, Viale P, Giannella M.   +20 more
europepmc   +1 more source

Epidemiology and Species Distribution of Candida Bloodstream Infections in a Comprehensive Cancer Center, 2008-2023. [PDF]

Mycopathologia
El-Atoum M, Chen GL, Segal BH, Bonnewell JP, Almyroudis NG.   +4 more
europepmc   +1 more source

Long‐Term Use of Rezafungin: A Case Report and Insights Into Real‐World Access

Transplant Infectious Disease, EarlyView.
Jian Mei Li, Jacqueline E. Clark, Tiffany Wu   +2 more
wiley   +1 more source

Extrapolation of in vitro effect concentrations to in vivo bioavailable concentrations using PBK modelling in humans for two classes of persistent and mobile compounds: triazoles and triazines. [PDF]

Arch Toxicol
Ravi Shankar AL, Irwan J, Spaenig M, Carlier M, Hansen T, Zumbülte N, Islam B, Lundquist P, Svensson R, Gouin T, Hamers T, Escher SE.   +11 more
europepmc   +1 more source

Study on Synthesis, Antiproliferative Properties, Immunomodulatory Effects, and Anti-Breast Cancer Activity of New Δ²-Pyrazoline-1H-1,2,3-Triazole Derivatives. [PDF]

Chem Biodivers
Khan SN, Moghtaderi H, Amirhossein E, Mohammadi S, Avula SK, Halim SA, Duran S, Rehman NU, Rahman SM, Khan A, Csuk R, Rostami A, Al-Harrasi A.   +12 more
europepmc   +1 more source

Novel C3/C28-bis-1,2,4-Triazolyl-sulfanylacetate-betulin Derivatives: Synthesis and Evaluation of Anticancer Potential. [PDF]

Int J Mol Sci
Prodea A, Mioc M, Munteanu A, Mioc A, Paşcalău NA, Mara BI, Atyim E, Balan-Porcarasu M, Racoviceanu R, Șoica C.   +9 more
europepmc   +1 more source

Phytotoxity of 3-amino-1, 2, 4-triazole for mulberry plants

The Journal of Sericultural Science of Japan, 1969
openaire   +1 more source